ICON PLC (ICLR)

Market Cap	23.76B
Revenue (ttm)	8.12B
Net Income (ttm)	612.34M
Shares Out	82.50M
EPS (ttm)	7.40
PE Ratio	39.38
Forward PE	20.58
Dividend	n/a
Ex-Dividend Date	n/a

Volume	209,451
Open	291.85
Previous Close	291.82
Day's Range	287.20 - 295.06
52-Week Range	181.92 - 344.77
Beta	1.16
Analysts	Strong Buy
Price Target	320.80 (+11.4%)
Earnings Date	Apr 24, 2024

About ICLR

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also offers clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient a...

• Industry: Diagnostics & Research
• Sector: Healthcare
• IPO Date: May 15, 1998
• Employees: 41,100
• Stock Exchange: NASDAQ
• Ticker Symbol: ICLR

Financial Performance

In 2023, ICON PLC's revenue was $8.12 billion, an increase of 4.89% compared to the previous year's $7.74 billion. Earnings were $612.34 million, an increase of 21.18%.

Analyst Forecast

According to 10 analysts, the average rating for ICLR stock is "Strong Buy." The 12-month stock price forecast is $320.8, which is an increase of 11.40% from the latest price.

Price Target

$320.8

(11.40% upside)

Analyst Consensus: Strong Buy